RENASANT BIO

Pharmaceutical preparations for the treatment of polycystic kidney disease, namely, autosomal dominant polycystic kidney disease (ADPKD); Pharmaceutical preparations for modulating polycystin ion channels for the treatment of autosomal dominant polycystic kidney disease (ADPKD); Pharmaceutical preparations for the treatment of kidney diseases and disorders; Pharmaceutical preparations for ion channel modulators for the treatment of kidney diseases and disorders; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, kidney diseases and disorders; Pharmaceutical preparations for the treatment of genetic kidney diseases

Pharmaceutical research in the field of kidney diseases and disorders; Pharmaceutical research in the field of drug discovery for kidney diseases and disorders; Pharmaceutical research in the field of autosomal dominant polycystic kidney disease (ADPKD); Pharmaceutical research in the field of ion channel pharmacology and electrophysiology related to kidney diseases and disorders; Research and development in the field of kidney diseases and disorders; Medical and scientific research information in the field of kidney diseases and disorders; Scientific and technological services, namely, design and development of biological assays for scientific research purposes in the field of kidney disease drug discovery and development